This study aimed to develop a joint population pharmacokinetic model for an antipsychotic agent in development (“type”:”entrez-protein”,”attrs”:S33138″S33138) and its own active metabolite (“type”:”entrez-protein”,”attrs”:S35424″S35424) made by reversible metabolism. metabolizer. Permutation testing had been performed to guarantee the robustness of the analysis, using SAEM buy 91374-21-9 and CF. In conclusion, we developed a complex joint pharmacokinetic model… Continue reading This study aimed to develop a joint population pharmacokinetic model for